Allelic Imbalance in TOR1A mRNA Expression in Manifesting and Non-Manifesting Carriers of the GAG-Deletion

Early onset dystonia (EOD) is associated with a 3bp-(ΔGAG) in-frame deletion in the TOR1A gene, which encodes for torsinA. Carriers of the mutant (ΔGAG) allele can either develop or escape a dystonic phenotype (~30% penetrance). The expression ratio of the two alleles could be important for the mani...

Full description

Saved in:
Bibliographic Details
Main Authors: Ioanna A. Armata, Andreas I. Diplas, Laurie J. Ozelius, Pullanipally Shashidharan
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Journal of Nucleic Acids
Online Access:http://dx.doi.org/10.1155/2012/985260
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849306096398761984
author Ioanna A. Armata
Andreas I. Diplas
Laurie J. Ozelius
Pullanipally Shashidharan
author_facet Ioanna A. Armata
Andreas I. Diplas
Laurie J. Ozelius
Pullanipally Shashidharan
author_sort Ioanna A. Armata
collection DOAJ
description Early onset dystonia (EOD) is associated with a 3bp-(ΔGAG) in-frame deletion in the TOR1A gene, which encodes for torsinA. Carriers of the mutant (ΔGAG) allele can either develop or escape a dystonic phenotype (~30% penetrance). The expression ratio of the two alleles could be important for the manifestation or prevention of the disease since wild-type (WT) torsinA is thought to have protective function. Absence of an antibody discriminating WT from ΔE torsinA has precluded the determination ΔE and WT torsinA levels in manifesting and nonmanifesting carriers. We performed quantitative analysis of TOR1A allele expression in manifesting (MC) and nonmanifesting (NMC) carriers using quantitative allele-specific PCR (qASPCR) to determine the levels of mutant versus WT torsinA mRNA. The technique described showed high degree of specificity in detecting the two alleles. The present study represents the first comprehensive analysis of biallelic expression of the TOR1A gene in lymphoblast and brain samples from patients and NMC relatives. We demonstrate that mRNA is transcribed from both the WT and ΔGAG allele in peripheral and neural tissues with a trend for increased expression of the ΔGAG allele compared to the WT in carriers regardless of their phenotype and thus cannot account for the reduced penetrance.
format Article
id doaj-art-308420765c5c4833b7ec95caa7e3511e
institution Kabale University
issn 2090-0201
2090-021X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Journal of Nucleic Acids
spelling doaj-art-308420765c5c4833b7ec95caa7e3511e2025-08-20T03:55:12ZengWileyJournal of Nucleic Acids2090-02012090-021X2012-01-01201210.1155/2012/985260985260Allelic Imbalance in TOR1A mRNA Expression in Manifesting and Non-Manifesting Carriers of the GAG-DeletionIoanna A. Armata0Andreas I. Diplas1Laurie J. Ozelius2Pullanipally Shashidharan3Department of Neurology and Radiology Massachusetts General Hospital and Program in Neuroscience, Harvard Medical School, Boston, MA 02114, USADepartment of Preventive Medicine, Mount Sinai School of Medicine, New York, NY 10029, USADepartment of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, NY 10029, USADepartment of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USAEarly onset dystonia (EOD) is associated with a 3bp-(ΔGAG) in-frame deletion in the TOR1A gene, which encodes for torsinA. Carriers of the mutant (ΔGAG) allele can either develop or escape a dystonic phenotype (~30% penetrance). The expression ratio of the two alleles could be important for the manifestation or prevention of the disease since wild-type (WT) torsinA is thought to have protective function. Absence of an antibody discriminating WT from ΔE torsinA has precluded the determination ΔE and WT torsinA levels in manifesting and nonmanifesting carriers. We performed quantitative analysis of TOR1A allele expression in manifesting (MC) and nonmanifesting (NMC) carriers using quantitative allele-specific PCR (qASPCR) to determine the levels of mutant versus WT torsinA mRNA. The technique described showed high degree of specificity in detecting the two alleles. The present study represents the first comprehensive analysis of biallelic expression of the TOR1A gene in lymphoblast and brain samples from patients and NMC relatives. We demonstrate that mRNA is transcribed from both the WT and ΔGAG allele in peripheral and neural tissues with a trend for increased expression of the ΔGAG allele compared to the WT in carriers regardless of their phenotype and thus cannot account for the reduced penetrance.http://dx.doi.org/10.1155/2012/985260
spellingShingle Ioanna A. Armata
Andreas I. Diplas
Laurie J. Ozelius
Pullanipally Shashidharan
Allelic Imbalance in TOR1A mRNA Expression in Manifesting and Non-Manifesting Carriers of the GAG-Deletion
Journal of Nucleic Acids
title Allelic Imbalance in TOR1A mRNA Expression in Manifesting and Non-Manifesting Carriers of the GAG-Deletion
title_full Allelic Imbalance in TOR1A mRNA Expression in Manifesting and Non-Manifesting Carriers of the GAG-Deletion
title_fullStr Allelic Imbalance in TOR1A mRNA Expression in Manifesting and Non-Manifesting Carriers of the GAG-Deletion
title_full_unstemmed Allelic Imbalance in TOR1A mRNA Expression in Manifesting and Non-Manifesting Carriers of the GAG-Deletion
title_short Allelic Imbalance in TOR1A mRNA Expression in Manifesting and Non-Manifesting Carriers of the GAG-Deletion
title_sort allelic imbalance in tor1a mrna expression in manifesting and non manifesting carriers of the gag deletion
url http://dx.doi.org/10.1155/2012/985260
work_keys_str_mv AT ioannaaarmata allelicimbalanceintor1amrnaexpressioninmanifestingandnonmanifestingcarriersofthegagdeletion
AT andreasidiplas allelicimbalanceintor1amrnaexpressioninmanifestingandnonmanifestingcarriersofthegagdeletion
AT lauriejozelius allelicimbalanceintor1amrnaexpressioninmanifestingandnonmanifestingcarriersofthegagdeletion
AT pullanipallyshashidharan allelicimbalanceintor1amrnaexpressioninmanifestingandnonmanifestingcarriersofthegagdeletion